OverviewChartNewsTraderScreen

BioCorRx/  US09073C2052  /

Nasdaq Other OTC
2024-04-19  9:51:25 PM Chg. 0.0000 Volume Bid- Ask- High Low
1.4700USD 0.00% 2,656
Turnover: 3,681.0800		 -Bid Size: - -Ask Size: - 1.4800 1.0500
GlobeNewswire 04-03 BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and S...
GlobeNewswire 04-02 BioCorRx Reports Business Update for 2023
GlobeNewswire 02-28 BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for R...
GlobeNewswire 02-08 BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
GlobeNewswire 01-09 BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President
GlobeNewswire 2023-11-14 BioCorRx Reports Business Update for the Third Quarter of 2023
GlobeNewswire 2023-08-15 BioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Na...
Newsfile Corp 2022-10-24 BioCorRx to Present at the LD Micro Main Event XV on October 25th
Newsfile Corp 2022-10-20 BioCorRx to Participate at the LD Micro Main Event XV
Newsfile Corp 2022-07-06 BioCorRX Inc. Discusses BICX104 Human Trials and 2B3D Metaverse Partnership with The Stock Day Podca...
Newsfile Corp 2022-04-19 BioCorRX Inc. Discusses FDA Approval Process for Implantable Naltrexone Pellet, BICX104, with The St...
GlobeNewswire 2022-03-22 BioCorRx to Participate in Two Upcoming Conferences
Newsfile Corp 2022-03-02 BioCorRx to Present at the Q1 Investor Summit Conference on March 9th
GlobeNewswire 2022-02-14 BioCorRx Announces Orange County Research Center as Clinical Trial Site for First-In-Human Clinical ...
GlobeNewswire 2022-01-05 BioCorRx to Present at the H.C. Wainwright BioConnect 2022 Conference
GlobeNewswire 2021-12-09 BioCorRx Appoints Drug Delivery Expert Jie Shen, Ph.D., to Scientific Advisory Board
GlobeNewswire 2021-11-24 BioCorRx to Participate in the Benzinga All Access Event on December 2nd
GlobeNewswire 2021-11-22 BioCorRx Acquires Intellectual Property for Drug Delivery
GlobeNewswire 2021-11-16 BioCorRx Provides Business Update for the Third Quarter of 2021
Newsfile Corp 2021-11-10 BioCorRx to Present at the Q4 Investor Summit Conference on November 16th
GlobeNewswire 2021-11-09 Recro Reports Third Quarter 2021 Financial Results
Newsfile Corp 2021-11-08 Investor Summit Group Provides Update on Upcoming Q4 Virtual Summit
GlobeNewswire 2021-11-05 Investor Summit Group Provides Update on Upcoming Q4 Virtual Summit
GlobeNewswire 2021-10-07 BioCorRx Files Patent Application with the Russian Patent Office (Rospatent) for Naltrexone Implant
GlobeNewswire 2021-09-29 BioCorRx to Present at LD Micro Main Event on Tuesday, October 12th